Engineering cocrystal solubility, stability, and pHmax by micellar solubilization

Journal of Pharmaceutical Sciences

Volumn 100, Issue 12, 2011, Pages 5219-5234

  Huang, Neal ^a   Rodríguez Hornedo, Naír ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acid base equilibria; Cocrystals; Crystal engineering; Micelle; PH; Solubility; Stabilization; Surfactants; Thermodynamics

Indexed keywords

CARBAMAZEPINE; DODECYL SULFATE SODIUM; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; CONCENTRATION (PARAMETERS); CRITICAL STABILIZATION CONCENTRATION; CRYSTAL STRUCTURE; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; MICELLE; PH; PHARMACEUTICAL ENGINEERING; PHYSICOCHEMICAL MODEL; SOLID; SOLUBILIZATION; THERMODYNAMICS; THERMOSTABILITY; X RAY POWDER DIFFRACTION;

EID: 80054965491     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22725     Document Type: Article

References (41)

1. Fleischman SG, Kuduva SS, McMahon JA, Moulton B, Walsh RDB, Rodríguez-Hornedo N, Zaworotko MJ. 2003. Crystal engineering of the composition of pharmaceutical phases: Multiple-component crystalline solids involving carbamazepine. Cryst Growth Des 3(6):909-919.
2. Childs SL, Hardcastle KI. 2007. Cocrystals of piroxicam with carboxylic acids. Cryst Growth Des 7(7):1291-1304.
3. Nehm SJ, Rodríguez-Spong B, Rodríguez-Hornedo N. 2006. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst Growth Des 6(2):592-600.
4. Bethune SJ, Huang N, Jayasankar A, Rodríguez-Hornedo N. 2009. Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility. Cryst Growth Des 9(9):3976-3988.
5. Jayasankar A, Reddy LS, Bethune SJ, Rodríguez-Hornedo N. 2009. Role of cocrystal and solution chemistry on the formation and stability of cocrystals with different stoichiometry. Cryst Growth Des 9(2):889-897.
6. Remenar JF, Peterson ML, Stephens PW, Zhang Z, Zimenkov Y, Hickey MB. 2007. Celecoxib:Nicotinamide dissociation: Using excipients to capture the cocrystal's potential. Mol Pharm 4(3):386-400.
7. McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A. 2006. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res 23(8):1888-1897.
8. Yadav AV, Dabke AP, Shete AS. Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. Drug Dev Ind Pharm 36(9):1036-1045.
9. Christian SD, Scamehorn JF. 1995. Solubilization in surfactant aggregates. Marcel Dekker, Inc., New York, New York.
10. Strickley RG. 2004. Solubilizing excipients in oral and injectable formulations. Pharm Res 21(2):201-230.
11. Wiedmann TS, Kamel L. 2002. Examination of the solubilization of drugs by bile salt micelles. J Pharm Sci 91(8):1743-1764.
12. Wiedmann TS, Bhatia R, Wattenberg LW. 2000. Drug solubilization in lung surfactant. J Control Release 65(1-2):43-47.
13. Serajuddin ATM, Sheen P-C, Mufson D, Bernstein DF, Augustine MA. 1988. Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions. J Pharm Sci 77(4):325-329.
14. Serajuddin ATM. 1999. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88(10):1058-1066.
15. Rodríguez-Hornedo N, Nehm SJ, Jayasankar A. 2006. Cocrystals: Design, properties and formation mechanisms. In Encyclopedia of Pharmaceutical Technology, Eds. Swarbrick and Boylan, Informa Health Care, London; 3rd ed. pp 615-635.
16. Rodríguez-Hornedo N, Nehm SJ, Seefeldt KF, Pagan-Torres Y, Falkiewicz CJ. 2006. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm 3:362-367.
17. Bak A, Gore A, Yanez E, Stanton M, Tufekcic S, Syed R, Akrami A, Rose M, Surapaneni S, Bostick T, King A, Neervannan S, Ostovic D, Koparkar A. 2008. The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. J Pharm Sci 97(9):3942-3956.
18. Schultheiss N, Newman A. 2009. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des 9(6):2950-2967.
19. Huang N, Rodríguez-Hornedo N. 2010. Effect of micellar solubilization on cocrystal solubility and stability. Cryst Growth Des 10(5):2050-2053.
20. Huang N, Rodríguez-Hornedo N. 2011. Engineering cocrystal thermodynamic stability and eutectic points by micellar solubilization and ionization. CrystEngComm 13(17):409-5422.
21. Nordström FL, Rasmuson ÅC. 2006. Solubility and melting properties of salicylic acid. J Chem Eng Data 51(5):1668-1671.
22. Williamson DS, Nagel DL, Markin RS, Cohen SM. 1987. Effect of pH and ions on the electronic structure of saccharin. Food Chem Toxicol 25(3):211-218.
23. Kojima S, Ichigabase H, Iguchi S. 1966. Studies on sweetening agents. VII. Absorption and excretion of sodium cyclamate (2). Chem Pharm Bull 14(9):965-971.
24. O'Neil M, Smith A, Heckelman P, Budavari S. 2001. The Merck Index. 13th ed. New York: John Wiley and Sons.
25. Robinson RA, Biggs AI. 1957. The ionization constants of p-aminobenzoic acid in aqueous solution at 25°C. Aust J Chem 10(2):128-134.
26. Li P, Tabibi SE, Yalkowsky SH. 1998. Combined effect of complexation and pH on solubilization. J Pharm Sci 87(12):1535-1537.
27. Jain A, Ran YQ, Yalkowsky SH. 2004. Effect of pH-sodium lauryl sulfate combination on solubilization of PG-300995 (an anti-HIV agent): A technical note. AAPS PharmSciTech 5(3):65-67.
28. He Y, Yalkowsky SH. 2006. Solubilization of monovalent weak electrolytes by micellization or complexation. Int J Pharm 314(1):15-20.
29. Good DJ, Rodríguez-Hornedo N. 2009. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des 9(5):2252-2264.
30. Bethune SJ. 2009. Thermodynamic and kinetic parameters that explain crystallization and solubility of pharmaceutical cocrystals. PhD Thesis; University of Michigan, Ann Arbor, MI.
31. Good DJ, Rodríguez-Hornedo N. 2010. Cocrystal eutectic constants and prediction of solubility behavior. Cryst Growth Des 10(3):1028-1032.
32. Rodríguez-Hornedo N, Murphy D. 2004. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. J Pharm Sci 93(2):449-460.
33. Mukerjee P, Mysels KJ. 1971. Critical micelle concentrations of aqueous surfactant systems. Washington, District of Columbia: US National Bureau of Standards.
34. Crison JR, Weiner ND, Amidon GL. 1997. Dissolution media for in vitro testing of water-insoluble drugs: Effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J Pharm Sci 86(3):384-388.
35. Seedher N, Kanojia M. 2008. Micellar solubilization of some poorly soluble antidiabetic drugs: A technical note. AAPS PharmSciTech 9(2):431-436.
36. Aburub A, Risley DS, Mishra D. 2008. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. Int J Pharm 347(1-2):16-22.
37. Moroi Y. 1992. Micelles: Theoretical and applied aspects. Plenum Press, New York, New York.
38. Rangel-Yagui CO, Junior AP, Tavares LC. 2005. Micellar solubilization of drugs. J Pharm Sci 8(2):147-163.
39. Pennell KD, Adinolfi AM, Abriola LM, Diallo MS. 1997. Solubilization of dodecane, tetrachloroethylene, and 1, 2-dichlorobenzene in micellar solutions of ethoxylated nonionic surfactants. Environ Sci Technol 31(5):1382-1389.
40. Stilbs P. 1983. A comparative study of micellar solubilization for combinations of surfactants and solubilizates using the Fourier transform pulsed-gradient spin-echo NMR multicomponent self-diffusion technique. J Colloid Interface Sci 94(2):463-469.
41. Hayworth JS, Burris DR. 1997. Nonionic surfactant-enhanced solubilization and recovery of organic contaminants from within cationic surfactant-enhanced sorbent zones. 1. Experiments. Environ Sci Technol 31(5):1277-1283.